#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Population immunity against hantavirus infection in two natural habitats


Authors: M. Pejčoch;  B. Kříž;  M. Malý
Authors place of work: Ředitelka: ing. Jitka Sosnovcová ;  Státní zdravotní ústav v Praze
Published in the journal: Prakt. Lék. 2010; 90(3): 167-170
Category: Of different specialties

Summary

At least three hantavirus genospecies are circulating in natural habitats in the Czech Republic:

  • Tula,
  • Puumala,
  • Dobrava - Belgrade.


All three viruses are pathogenic for humans and are able to cause nephropathia epidemica of varying degrees of seriousness. An outbreak of diseases caused by the Puumala virus occurred in the region in and around the town of Prachatice. We investigated the antibodies of a random selected 1081 sera of healthy persons from the affected region, which were deposited in the serum bank of the National Public Health Institute in Prague. Additionally we investigated 423 sera of healthy persons from the Vsetin area, where four cases of hantavirus infections were detected. 1.76% and 1.18% hantavirus immunity rate has been detected in the Prachatice area and Vsetin area respectively. This finding is in correlation with the results of studies performed in other parts of the country. It means that the overall risk of Hantavirus infection in the areas mentioned is not high. Therefore it is persons entering the Hantavirus natural foci for work or leisure activities who are mainly at risk of infection.

Key words:
hantaviruses, Puumala, seroprevalence, Czech Republic.


Zdroje

1. Ahlm, C., Linderholm, M., Juto, P. et al. Prevalence of serum IgG antibodies to Puumala virus in Northern Sweden. Epidemiol. Infect. 1994, 113(1), p. 129-136.

2. Ahlm, C., Thelin, A., Elgh, F. et al. Prevalence of antibodies specific to Puumala virus among farmers in Sweden. Scand. J. Work Environ. Health 1998, 24(2), p. 104-108.

3. Daneš, L., Pavlíčková, E., Kobzík, J. a kol. Anti-hantavirus antibodies in human sera in Czechoslovakia. J. Hyg. Epidemiol. Microbiol. Immunol.1992, 36(1), p. 55-62.

4. Daneš, L. Hemorrhagická horečka s ledvinným syndromem (HHLS). Acta Hyg. Epid. Microbiol. 1985, 15, 2, s. 52-57.

5. Deutz, A., Fuchs, K., Schuller, W. et al. Seroepidemiologische Untersuchung von Jägern auf Zoonosen in Südostösterreich - Prävalenzen, Risikopotentiale und Vorbeugemaßnahmen. Berl. Munch. Tierarztl. Wochenschr. 2003, 116(7/8) s. 306-311.

6. Gegúndez, M. I., Saz, J. V., Alves, M. J. et al. Infección por Hantavirus en España: estudio seroepidemiológico en la provincia de Soria. Med. Clin. (Barcelona), 1996, 106(4) p. 131-133.

7. Gerding, M. N., Groen, J., Jordans, J. G., Osterhaus, A. D. Hantavirus nephropathy in the Netherlands: clinical, histopathological and epidemiological findings. Neth. J. Med. 1995, 47(3), p. 106-112.

8. Heyman, P., Vaheri, A. Situation of hantavirus infections and hemorrhagic fever with renal syndrome in European countries as of December 2006. Euro Surveill. 2008, 13, 28, 18925 (on-line). Dostupné na http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18925.

9. Heyman, P., Vaheri, A., Lundkvist, A., Avsic-Zupanc, T. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev. Anti Infect. Ther. 2009, 7(2), p. 205-217.

10. Klempa, B., Meisel, H., Rath, S. et al. Occurence of renal and pulmonary syndrome in a region of northeast Germany where Tula Hantavirus circulates. J. Clin. Microbiol. 2003, 41(10), p. 4894-4897.

11. Lanžhotský, M., Čechová, P. Kazuistiky čtyř pacientů s akutním renálním selháním a hantavirovou hemorrhagickou horečkou. Interní Med. 2003, 11, s. 563-565.

12. Linderholm, M., Elgh, F. Clinical characteristics of hantavirus infections on the Eurasian continent. Curr. Top. Microbiol. Immunol. 2000, 256, p. 135-151.

13. Lledó, L., Klingstrom, J., Gegundez, M. I. et al. Hantavirus infections in Spain: Analysis of sera from the general population and from patients with pneumonia, renal disease and hepatitis. J. Clin. Virol. 2003, 27(3), p. 296- 307.

14. Martens, H. Serologische Untersuchungen zur Prevalenz und zum Verlauf von Hantavirus-Infektionen in Mecklenburg-Vorpommern. Gesundheitswesen, 2000, 62(2) s. 71-77.

15. Mertens, M., Wölfel, R., Ullrich. K. Seroepidemiological study in a Puumala virus outbreak area in South-East Germany. Med. Microbiol. Immunol. 2009, 198(2), p. 83-91.

16. Nuti, M., Amaddeo, D., Autorino, G. L. et al. Seroprevalence of antibodies to hantaviruses and leptospires in selected Italian population groups. Eur. J. Epidemiol. 1992, 8(1), p. 98-102.

17. Pazdiora, P., Daneš, L., Januška, J., Nocarová, D. Prevalence protilátek proti hantavirům a viru klíšťové encefalitidy u obyvatel okresu Plzeň-jih. Prakt. Lék., 1998, 78(2), s. 69-71.

18. Pejčoch, M., Kříž, B. Prevalence of antibodies against hantaviruses among the adult population of the Czech Republic. Centr. Eur. J. Publ. Health 2003, 11(3), p. 169-172.

19. Plyusnin, A., Cheng, Y., Vapalahti, O. Genetic variation in Tula hantaviruses: sequence analysis of the S and M segments of strains from central Europe. Virus Research 1995, 39(2/3), p. 237-250.

20. Plyusnin, A., Vapalahti, O., Vaheri, A. Hantaviruses: genome structure, expression and evolution. J. Gen. Virol. 1996, 77(11), p. 2677-2687.

21. Sandmann, S., Meisel, H., Razanskiene, A. Detection of human hantavirus infections in Lithuania. Infection, 2005, 33(2), p. 66-72.

22. Sibold, C., Meisel, H., Lundkvist, A. et al. Short report: Simultaneous occurrence of Dobrava, Puumala, and Tula hantaviruses in Slovakia. Amer. J. Trop. Med. Hyg. 1999, 61(3), p. 409-411.

23. Ulrich, R.G., Schmidt-Chanasir, J., Schlegel, M. et al. Network „Rodent-borne pathogens“ in Germany: Longitudinal studies on the geographical distribution and prevalence of hantavirus infections. Parasitol. Res. 2008, 103, Suppl 1, S121-129.

24. Vacková, M., Douda, P., Beran, J. et al. Sérologický průkaz hantavirových protilátek. Epidemiol. Mikrobiol. Imunol. 2002, 51(2), s. 74-77.

25. Vapalahti, O., Lundkvist, A., Kukkonen, S. K., et al. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J. Gen. Virol. 1996, 77(12), p. 3063-3067.

26. Weidmann, M., Schmidt, P., Vackova, M. et al. Identification of genetic evidence for Dobrava virus spillover in rodents by nested reverse transcription (RT)-PCR and TaqMan RT-PCR. J. Clin. Microbiol. 2005, 43(2), p. 808-812.

27. Zelená, H., Januška, J. Výsledky sérologie hantavirů z klinických vzorků vyšetřených v období 1998-2008 na oddělení virologie Zdravotního ústavu v Ostravě. Epidemiol. Mikrobiol. Imunol. 2009, 58(3), s. 115-120.

28. Zöller, L., Faulde, M., Meisel, H. et al. Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur. J. Clin. Microbiol. Inf. Dis. 1995, 14(4), p. 305-313.

Štítky
General practitioner for children and adolescents General practitioner for adults
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#